<?xml version='1.0' encoding='UTF-8'?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" 
         xmlns:bmdb="http://edrn.nci.nih.gov/rdf/rdfs/bmdb-1.0.0#"
         xmlns:edrn="http://edrn.nci.nih.gov/rdf/schema.rdf#"
         xmlns:edrntype="http://edrn.nci.nih.gov/rdf/types.rdf#" 
         xmlns:dc="http://purl.org/dc/terms/">
  <edrntype:Publication rdf:about="http://edrn.jpl.nasa.gov/bmdb/publications/view/7">
    <dc:title>Mesothelin variant 1 is released from tumor cells as a diagnostic marker.</dc:title>
    <dc:author>Hellstrom KE</dc:author>
    <edrn:journal>Cancer Epidemiol Biomarkers Prev</edrn:journal>
    <bmdb:Published>2006 May</bmdb:Published>
    <edrn:pmid>16702385</edrn:pmid>
  </edrntype:Publication>
  <edrntype:Publication rdf:about="http://edrn.jpl.nasa.gov/bmdb/publications/view/3">
    <dc:title>A functional arginine residue in NADPH-dependent aldehyde reductase from pig kidney.</dc:title>
    <dc:author>Flynn TG</dc:author>
    <edrn:journal>J Biol Chem</edrn:journal>
    <bmdb:Published>1979 May 25</bmdb:Published>
    <edrn:pmid>35531</edrn:pmid>
  </edrntype:Publication>
  <edrntype:Publication rdf:about="http://edrn.jpl.nasa.gov/bmdb/publications/view/4">
    <dc:title>Serum immunoglobulins in fixed drug eruption.</dc:title>
    <dc:author>Capetanakis J</dc:author>
    <edrn:journal>Acta Derm Venereol</edrn:journal>
    <bmdb:Published>1977</bmdb:Published>
    <edrn:pmid>73325</edrn:pmid>
  </edrntype:Publication>
  <edrntype:Publication rdf:about="http://edrn.jpl.nasa.gov/bmdb/publications/view/5">
    <dc:title>The fate of cartilage grafts for ossicular reconstruction in tympanoplasty.</dc:title>
    <dc:author>Linthicum FH Jr</dc:author>
    <edrn:journal>Ann Otol Rhinol Laryngol</edrn:journal>
    <bmdb:Published>1975 Mar-Apr</bmdb:Published>
    <edrn:pmid>47732</edrn:pmid>
  </edrntype:Publication>
  <edrntype:Publication rdf:about="http://edrn.jpl.nasa.gov/bmdb/publications/view/6">
    <dc:title>Construction and selection of recombinant plasmids containing full-length complementary DNAs corresponding to rat insulins I and II.</dc:title>
    <dc:author>Steiner DF</dc:author>
    <edrn:journal>Proc Natl Acad Sci U S A</edrn:journal>
    <bmdb:Published>1979 Oct</bmdb:Published>
    <edrn:pmid>388427</edrn:pmid>
  </edrntype:Publication>
  <edrntype:Publication rdf:about="http://edrn.jpl.nasa.gov/bmdb/publications/view/8">
    <dc:title>A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer.</dc:title>
    <dc:author>Knapp RC</dc:author>
    <edrn:journal>N Engl J Med</edrn:journal>
    <bmdb:Published>1983 Oct 13</bmdb:Published>
    <edrn:pmid>6310399</edrn:pmid>
  </edrntype:Publication>
  <edrntype:Publication rdf:about="http://edrn.jpl.nasa.gov/bmdb/publications/view/9">
    <dc:title>Human kallikrein 6 (zyme/protease M/neurosin): a new serum biomarker of ovarian carcinoma.</dc:title>
    <dc:author>Bunting P</dc:author>
    <edrn:journal>Clin Biochem</edrn:journal>
    <bmdb:Published>2000 Oct</bmdb:Published>
    <edrn:pmid>11124344</edrn:pmid>
  </edrntype:Publication>
  <edrntype:Publication rdf:about="http://edrn.jpl.nasa.gov/bmdb/publications/view/10">
    <dc:title>Serum and tissue measurements of CA72-4 in ovarian cancer patients.</dc:title>
    <dc:author>Asano G</dc:author>
    <edrn:journal>Gynecol Oncol</edrn:journal>
    <bmdb:Published>1993 Feb</bmdb:Published>
    <edrn:pmid>8381375</edrn:pmid>
  </edrntype:Publication>
  <edrntype:Publication rdf:about="http://edrn.jpl.nasa.gov/bmdb/publications/view/11">
    <dc:title>B7-h4 is a novel membrane-bound protein and a candidate serum and tissue biomarker for ovarian cancer.</dc:title>
    <dc:author>Kim NW</dc:author>
    <edrn:journal>Cancer Res</edrn:journal>
    <bmdb:Published>2006 Feb 1</bmdb:Published>
    <edrn:pmid>16452214</edrn:pmid>
  </edrntype:Publication>
  <edrntype:Publication rdf:about="http://edrn.jpl.nasa.gov/bmdb/publications/view/12">
    <dc:title>Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas.</dc:title>
    <dc:author>Hecht JL</dc:author>
    <edrn:journal>Cancer Res</edrn:journal>
    <bmdb:Published>2005 Mar 15</bmdb:Published>
    <edrn:pmid>15781627</edrn:pmid>
  </edrntype:Publication>
  <edrntype:Publication rdf:about="http://edrn.jpl.nasa.gov/bmdb/publications/view/13">
    <dc:title>CA19-9 as a marker for ovarian cancer: alone and in comparison with CA125.</dc:title>
    <dc:author>Moore M</dc:author>
    <edrn:journal>Br J Cancer</edrn:journal>
    <bmdb:Published>1985 Jul</bmdb:Published>
    <edrn:pmid>2410004</edrn:pmid>
  </edrntype:Publication>
  <edrntype:Publication rdf:about="http://edrn.jpl.nasa.gov/bmdb/publications/view/14">
    <dc:title>Correlation of CA125 and CA19-9 serum levels with clinical course and second-look findings in patients with ovarian carcinoma.</dc:title>
    <dc:author>Facchini V</dc:author>
    <edrn:journal>Gynecol Oncol</edrn:journal>
    <bmdb:Published>1987 Nov</bmdb:Published>
    <edrn:pmid>3479380</edrn:pmid>
  </edrntype:Publication>
  <edrntype:Publication rdf:about="http://edrn.jpl.nasa.gov/bmdb/publications/view/15">
    <dc:title>Pre-operative discrimination between benign and malignant ovarian tumors using a combination of CA125 and CA15.3 serum assays.</dc:title>
    <dc:author>Kenemans P</dc:author>
    <edrn:journal>Int J Cancer Suppl</edrn:journal>
    <bmdb:Published>1988</bmdb:Published>
    <edrn:pmid>3209301</edrn:pmid>
  </edrntype:Publication>
  <edrntype:Publication rdf:about="http://edrn.jpl.nasa.gov/bmdb/publications/view/16">
    <dc:title>Coordinate elevation of serum markers in ovarian cancer but not in benign disease.</dc:title>
    <dc:author>Knapp RC</dc:author>
    <edrn:journal>Cancer</edrn:journal>
    <bmdb:Published>1991 Oct 15</bmdb:Published>
    <edrn:pmid>1913520</edrn:pmid>
  </edrntype:Publication>
  <edrntype:Publication rdf:about="http://edrn.jpl.nasa.gov/bmdb/publications/view/17">
    <dc:title>Strategies for improving the specificity of screening for ovarian cancer with tumor-associated antigens CA 125, CA 15-3, and TAG 72.3.</dc:title>
    <dc:author>Bast RC Jr</dc:author>
    <edrn:journal>Obstet Gynecol</edrn:journal>
    <bmdb:Published>1992 Sep</bmdb:Published>
    <edrn:pmid>1495694</edrn:pmid>
  </edrntype:Publication>
  <edrntype:Publication rdf:about="http://edrn.jpl.nasa.gov/bmdb/publications/view/18">
    <dc:title>Small integrin-binding ligand N-linked glycoproteins (SIBLINGs): multifunctional proteins in cancer.</dc:title>
    <dc:author>Fedarko NS</dc:author>
    <edrn:journal>Nat Rev Cancer</edrn:journal>
    <bmdb:Published>2008 Mar</bmdb:Published>
    <edrn:pmid>18292776</edrn:pmid>
  </edrntype:Publication>
  <edrntype:Publication rdf:about="http://edrn.jpl.nasa.gov/bmdb/publications/view/19">
    <dc:title>Mesothelin variant 1 is released from tumor cells as a diagnostic marker.</dc:title>
    <dc:author>Hellstrom KE</dc:author>
    <edrn:journal>Cancer Epidemiol Biomarkers Prev</edrn:journal>
    <bmdb:Published>2006 May</bmdb:Published>
    <edrn:pmid>16702385</edrn:pmid>
  </edrntype:Publication>
  <edrntype:Publication rdf:about="http://edrn.jpl.nasa.gov/bmdb/publications/view/20">
    <dc:title>Vascular endothelial growth factor stimulates organ-specific host matrix metalloproteinase-9 expression and ovarian cancer invasion.</dc:title>
    <dc:author>Taraboletti G</dc:author>
    <edrn:journal>Mol Cancer Res</edrn:journal>
    <bmdb:Published>2008 Apr</bmdb:Published>
    <edrn:pmid>18403633</edrn:pmid>
  </edrntype:Publication>
  <edrntype:Publication rdf:about="http://edrn.jpl.nasa.gov/bmdb/publications/view/21">
    <dc:title>Asbestos exposure, pleural mesothelioma, and serum osteopontin levels.</dc:title>
    <dc:author>Wali A</dc:author>
    <edrn:journal>N Engl J Med</edrn:journal>
    <bmdb:Published>2005 Oct 13</bmdb:Published>
    <edrn:pmid>16221779</edrn:pmid>
  </edrntype:Publication>
  <edrntype:Publication rdf:about="http://edrn.jpl.nasa.gov/bmdb/publications/view/22">
    <dc:title>Differential gene expression of primary cultured lymphatic and blood vascular endothelial cells.</dc:title>
    <dc:author>Jain RK</dc:author>
    <edrn:journal>Neoplasia</edrn:journal>
    <bmdb:Published>2007 Dec</bmdb:Published>
    <edrn:pmid>18084611</edrn:pmid>
  </edrntype:Publication>
  <edrntype:Publication rdf:about="http://edrn.jpl.nasa.gov/bmdb/publications/view/23">
    <dc:title>Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in american patients.</dc:title>
    <dc:author>Lok AS</dc:author>
    <edrn:journal>Hepatology</edrn:journal>
    <bmdb:Published>2003 May</bmdb:Published>
    <edrn:pmid>12717392</edrn:pmid>
  </edrntype:Publication>
  <edrntype:Publication rdf:about="http://edrn.jpl.nasa.gov/bmdb/publications/view/24">
    <dc:title>Molecular detection of primary bladder cancer by microsatellite analysis.</dc:title>
    <dc:author>Sidransky D</dc:author>
    <edrn:journal>Science</edrn:journal>
    <bmdb:Published>1996 Feb 2</bmdb:Published>
    <edrn:pmid>8571131</edrn:pmid>
  </edrntype:Publication>
  <edrntype:Publication rdf:about="http://edrn.jpl.nasa.gov/bmdb/publications/view/25">
    <dc:title>An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer.</dc:title>
    <dc:author>Hanash SM</dc:author>
    <edrn:journal>Proc Natl Acad Sci U S A</edrn:journal>
    <bmdb:Published>2001 Aug 14</bmdb:Published>
    <edrn:pmid>11504947</edrn:pmid>
  </edrntype:Publication>
  <edrntype:Publication rdf:about="http://edrn.jpl.nasa.gov/bmdb/publications/view/26">
    <dc:title>Integral protein microarrays for the identification of lung cancer antigens in sera that induce a humoral immune response.</dc:title>
    <dc:author>Hanash SM</dc:author>
    <edrn:journal>Mol Cell Proteomics</edrn:journal>
    <bmdb:Published>2008 Feb</bmdb:Published>
    <edrn:pmid>17916591</edrn:pmid>
  </edrntype:Publication>
  <edrntype:Publication rdf:about="http://edrn.jpl.nasa.gov/bmdb/publications/view/27">
    <dc:title>Occurrence of Autoantibodies to Annexin I, 14-3-3 Theta and LAMR1 in Prediagnostic Lung Cancer Sera.</dc:title>
    <dc:author>Hanash SM</dc:author>
    <edrn:journal>J Clin Oncol</edrn:journal>
    <bmdb:Published>2008 Sep 15</bmdb:Published>
    <edrn:pmid>18794547</edrn:pmid>
  </edrntype:Publication>
  <edrntype:Publication rdf:about="http://edrn.jpl.nasa.gov/bmdb/publications/view/28">
    <dc:title>Identification of 14-3-3 theta as an antigen that induces a humoral response in lung cancer.</dc:title>
    <dc:author>Hanash SM</dc:author>
    <edrn:journal>Cancer Res</edrn:journal>
    <bmdb:Published>2007 Dec 15</bmdb:Published>
    <edrn:pmid>18089831</edrn:pmid>
  </edrntype:Publication>
  <edrntype:Publication rdf:about="http://edrn.jpl.nasa.gov/bmdb/publications/view/29">
    <dc:title>Isoform-specific expression of 14-3-3 proteins in human lung cancer tissues.</dc:title>
    <dc:author>Martinez JD</dc:author>
    <edrn:journal>Int J Cancer</edrn:journal>
    <bmdb:Published>2005 Jan 20</bmdb:Published>
    <edrn:pmid>15455356</edrn:pmid>
  </edrntype:Publication>
  <edrntype:Publication rdf:about="http://edrn.jpl.nasa.gov/bmdb/publications/view/30">
    <dc:title>Reduction of 14-3-3 proteins correlates with increased sensitivity to killing of human lung cancer cells by ionizing radiation.</dc:title>
    <dc:author>Martinez JD</dc:author>
    <edrn:journal>Radiat Res</edrn:journal>
    <bmdb:Published>2003 Aug</bmdb:Published>
    <edrn:pmid>12859233</edrn:pmid>
  </edrntype:Publication>
  <edrntype:Publication rdf:about="http://edrn.jpl.nasa.gov/bmdb/publications/view/31">
    <dc:title>Cloning of 67-kDa laminin receptor cDNA and gene expression in normal and malignant cell lines of the human lung.</dc:title>
    <dc:author>Motomiya M</dc:author>
    <edrn:journal>Cancer Lett</edrn:journal>
    <bmdb:Published>1992 Mar 15</bmdb:Published>
    <edrn:pmid>1534510</edrn:pmid>
  </edrntype:Publication>
  <edrntype:Publication rdf:about="http://edrn.jpl.nasa.gov/bmdb/publications/view/32">
    <dc:title>Identification of 14-3-3 theta as an antigen that induces a humoral response in lung cancer.</dc:title>
    <dc:author>Hanash SM</dc:author>
    <edrn:journal>Cancer Res</edrn:journal>
    <bmdb:Published>2007 Dec 15</bmdb:Published>
    <edrn:pmid>18089831</edrn:pmid>
  </edrntype:Publication>
  <edrntype:Publication rdf:about="http://edrn.jpl.nasa.gov/bmdb/publications/view/33">
    <dc:title>Risk factors for hepatocellular carcinoma may impair the performance of biomarkers: a comparison of AFP, DCP, and AFP-L3.</dc:title>
    <dc:author>Marrero JA</dc:author>
    <edrn:journal>Cancer Biomark</edrn:journal>
    <bmdb:Published>2007</bmdb:Published>
    <edrn:pmid>17522429</edrn:pmid>
  </edrntype:Publication>
  <edrntype:Publication rdf:about="http://edrn.jpl.nasa.gov/bmdb/publications/view/34">
    <dc:title>Des-gamma-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma.</dc:title>
    <dc:author>Furie B</dc:author>
    <edrn:journal>N Engl J Med</edrn:journal>
    <bmdb:Published>1984 May 31</bmdb:Published>
    <edrn:pmid>6201741</edrn:pmid>
  </edrntype:Publication>
  <edrntype:Publication rdf:about="http://edrn.jpl.nasa.gov/bmdb/publications/view/35">
    <dc:title>Blood and urine markers for ovarian cancer: a comprehensive review.</dc:title>
    <dc:author>Cramer DW</dc:author>
    <edrn:journal>Dis Markers</edrn:journal>
    <bmdb:Published>2004</bmdb:Published>
    <edrn:pmid>15322314</edrn:pmid>
  </edrntype:Publication>
  <edrntype:Publication rdf:about="http://edrn.jpl.nasa.gov/bmdb/publications/view/36">
    <dc:title>AFP-L3: a new generation of tumor marker for hepatocellular carcinoma.</dc:title>
    <dc:author>Satomura S</dc:author>
    <edrn:journal>Clin Chim Acta</edrn:journal>
    <bmdb:Published>2001 Nov</bmdb:Published>
    <edrn:pmid>11694234</edrn:pmid>
  </edrntype:Publication>
  <edrntype:Publication rdf:about="http://edrn.jpl.nasa.gov/bmdb/publications/view/37">
    <dc:title>Serum tumor markers for detection of hepatocellular carcinoma.</dc:title>
    <dc:author>Luo F</dc:author>
    <edrn:journal>World J Gastroenterol</edrn:journal>
    <bmdb:Published>2006 Feb 28</bmdb:Published>
    <edrn:pmid>16534867</edrn:pmid>
  </edrntype:Publication>
  <edrntype:Publication rdf:about="http://edrn.jpl.nasa.gov/bmdb/publications/view/38">
    <dc:title>Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.</dc:title>
    <dc:author>Tong MJ</dc:author>
    <edrn:journal>J Gastroenterol Hepatol</edrn:journal>
    <bmdb:Published>2008 Oct</bmdb:Published>
    <edrn:pmid>18422961</edrn:pmid>
  </edrntype:Publication>
  <edrntype:Publication rdf:about="http://edrn.jpl.nasa.gov/bmdb/publications/view/39">
    <dc:title>The role of PGP9.5 as a tumor suppressor gene in human cancer.</dc:title>
    <dc:author>Sidransky D</dc:author>
    <edrn:journal>Int J Cancer</edrn:journal>
    <bmdb:Published>2008 Aug 15</bmdb:Published>
    <edrn:pmid>18512240</edrn:pmid>
  </edrntype:Publication>
  <edrntype:Publication rdf:about="http://edrn.jpl.nasa.gov/bmdb/publications/view/40">
    <dc:title>Determination of metastasis-associated proteins in non-small cell lung cancer by comparative proteomic analysis.</dc:title>
    <dc:author>He D</dc:author>
    <edrn:journal>Cancer Sci</edrn:journal>
    <bmdb:Published>2007 Aug</bmdb:Published>
    <edrn:pmid>17537172</edrn:pmid>
  </edrntype:Publication>
  <edrntype:Publication rdf:about="http://edrn.jpl.nasa.gov/bmdb/publications/view/41">
    <dc:title>Ubiquitin C-terminal hydrolase-L1 is a key regulator of tumor cell invasion and metastasis.</dc:title>
    <dc:author>Lee KJ</dc:author>
    <edrn:journal>Oncogene</edrn:journal>
    <bmdb:Published>2009 Jan 8</bmdb:Published>
    <edrn:pmid>18820707</edrn:pmid>
  </edrntype:Publication>
  <edrntype:Publication rdf:about="http://edrn.jpl.nasa.gov/bmdb/publications/view/42">
    <dc:title>Soluble mesothelin-related peptide level elevation in mesothelioma serum and pleural effusions.</dc:title>
    <dc:author>Allard J</dc:author>
    <edrn:journal>Ann Thorac Surg</edrn:journal>
    <bmdb:Published>2008 Jan</bmdb:Published>
    <edrn:pmid>18154821</edrn:pmid>
  </edrntype:Publication>
  <edrntype:Publication rdf:about="http://edrn.jpl.nasa.gov/bmdb/publications/view/43">
    <dc:title>Cellular and molecular parameters of mesothelioma.</dc:title>
    <dc:author>Mossman BT</dc:author>
    <edrn:journal>J Cell Biochem</edrn:journal>
    <bmdb:Published>2006 Jul 1</bmdb:Published>
    <edrn:pmid>16795078</edrn:pmid>
  </edrntype:Publication>
  <edrntype:Publication rdf:about="http://edrn.jpl.nasa.gov/bmdb/publications/view/44">
    <dc:title>DJ-1, a cancer- and Parkinson&amp;apos;s disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2.</dc:title>
    <dc:author>Ting JP</dc:author>
    <edrn:journal>Proc Natl Acad Sci U S A</edrn:journal>
    <bmdb:Published>2006 Oct 10</bmdb:Published>
    <edrn:pmid>17015834</edrn:pmid>
  </edrntype:Publication>
  <edrntype:Publication rdf:about="http://edrn.jpl.nasa.gov/bmdb/publications/view/45">
    <dc:title>Overexpression of squamous cell carcinoma antigen variants in hepatocellular carcinoma.</dc:title>
    <dc:author>Fassina G</dc:author>
    <edrn:journal>Br J Cancer</edrn:journal>
    <bmdb:Published>2004 Feb 23</bmdb:Published>
    <edrn:pmid>14970861</edrn:pmid>
  </edrntype:Publication>
  <edrntype:Publication rdf:about="http://edrn.jpl.nasa.gov/bmdb/publications/view/46">
    <dc:title>Squamous cell carcinoma antigen in human liver carcinogenesis.</dc:title>
    <dc:author>Rugge M</dc:author>
    <edrn:journal>J Clin Pathol</edrn:journal>
    <bmdb:Published>2008 Apr</bmdb:Published>
    <edrn:pmid>17893121</edrn:pmid>
  </edrntype:Publication>
  <edrntype:Publication rdf:about="http://edrn.jpl.nasa.gov/bmdb/publications/view/47">
    <dc:title>Clinical role of tissue and serum levels of SCCA antigen in hepatocellular carcinoma.</dc:title>
    <dc:author>Antonaci S</dc:author>
    <edrn:journal>Int J Cancer</edrn:journal>
    <bmdb:Published>2005 Sep 10</bmdb:Published>
    <edrn:pmid>15825162</edrn:pmid>
  </edrntype:Publication>
  <edrntype:Publication rdf:about="http://edrn.jpl.nasa.gov/bmdb/publications/view/48">
    <dc:title>Lentiviral-mediated miRNA against osteopontin suppresses tumor growth and metastasis of human hepatocellular carcinoma.</dc:title>
    <dc:author>Qin LX</dc:author>
    <edrn:journal>Hepatology</edrn:journal>
    <bmdb:Published>2008 Dec</bmdb:Published>
    <edrn:pmid>18972404</edrn:pmid>
  </edrntype:Publication>
  <edrntype:Publication rdf:about="http://edrn.jpl.nasa.gov/bmdb/publications/view/49">
    <dc:title>Promoter hypermethylation of CDH13 is a common, early event in human esophageal adenocarcinogenesis and correlates with clinical risk factors.</dc:title>
    <dc:author>Meltzer SJ</dc:author>
    <edrn:journal>Int J Cancer</edrn:journal>
    <bmdb:Published>2008 Nov 15</bmdb:Published>
    <edrn:pmid>18729198</edrn:pmid>
  </edrntype:Publication>
  <edrntype:Publication rdf:about="http://edrn.jpl.nasa.gov/bmdb/publications/view/50">
    <dc:title>Methylation pattern of CDH13 gene in digestive tract cancers.</dc:title>
    <dc:author>Nakao A</dc:author>
    <edrn:journal>Br J Cancer</edrn:journal>
    <bmdb:Published>2004 Sep 13</bmdb:Published>
    <edrn:pmid>15292927</edrn:pmid>
  </edrntype:Publication>
  <edrntype:Publication rdf:about="http://edrn.jpl.nasa.gov/bmdb/publications/view/51">
    <dc:title>Three-tiered risk stratification model to predict progression in Barrett&amp;apos;s esophagus using epigenetic and clinical features.</dc:title>
    <dc:author>Meltzer SJ</dc:author>
    <edrn:journal>PLoS ONE</edrn:journal>
    <bmdb:Published>2008 Apr 2</bmdb:Published>
    <edrn:pmid>18382671</edrn:pmid>
  </edrntype:Publication>
  <edrntype:Publication rdf:about="http://edrn.jpl.nasa.gov/bmdb/publications/view/52">
    <dc:title>Hypermethylation of the nel-like 1 gene is a common and early event and is associated with poor prognosis in early-stage esophageal adenocarcinoma.</dc:title>
    <dc:author>Meltzer SJ</dc:author>
    <edrn:journal>Oncogene</edrn:journal>
    <bmdb:Published>2007 Sep 20</bmdb:Published>
    <edrn:pmid>17452981</edrn:pmid>
  </edrntype:Publication>
  <edrntype:Publication rdf:about="http://edrn.jpl.nasa.gov/bmdb/publications/view/53">
    <dc:title>Similarity of aberrant DNA methylation in Barrett&amp;apos;s esophagus and esophageal adenocarcinoma.</dc:title>
    <dc:author>Drew PA</dc:author>
    <edrn:journal>Mol Cancer</edrn:journal>
    <bmdb:Published>2008 Oct 2</bmdb:Published>
    <edrn:pmid>18831746</edrn:pmid>
  </edrntype:Publication>
  <edrntype:Publication rdf:about="http://edrn.jpl.nasa.gov/bmdb/publications/view/54">
    <dc:title>Inactivation of p16, RUNX3, and HPP1 occurs early in Barrett&amp;apos;s-associated neoplastic progression and predicts progression risk.</dc:title>
    <dc:author>Meltzer SJ</dc:author>
    <edrn:journal>Oncogene</edrn:journal>
    <bmdb:Published>2005 Jun 9</bmdb:Published>
    <edrn:pmid>15824739</edrn:pmid>
  </edrntype:Publication>
  <edrntype:Publication rdf:about="http://edrn.jpl.nasa.gov/bmdb/publications/view/55">
    <dc:title>Hypermethylation of the somatostatin promoter is a common, early event in human esophageal carcinogenesis.</dc:title>
    <dc:author>Meltzer SJ</dc:author>
    <edrn:journal>Cancer</edrn:journal>
    <bmdb:Published>2008 Jan 1</bmdb:Published>
    <edrn:pmid>17999418</edrn:pmid>
  </edrntype:Publication>
  <edrntype:Publication rdf:about="http://edrn.jpl.nasa.gov/bmdb/publications/view/56">
    <dc:title>CpG island hypermethylation in progression of esophageal and gastric cancer.</dc:title>
    <dc:author>Meltzer SJ</dc:author>
    <edrn:journal>Cancer</edrn:journal>
    <bmdb:Published>2006 Feb 1</bmdb:Published>
    <edrn:pmid>16362978</edrn:pmid>
  </edrntype:Publication>
  <edrntype:Publication rdf:about="http://edrn.jpl.nasa.gov/bmdb/publications/view/57">
    <dc:title>Distinct TPEF/HPP1 gene methylation patterns in gastric cancer indicate a field effect in gastric carcinogenesis.</dc:title>
    <dc:author>Malfertheiner P</dc:author>
    <edrn:journal>Dig Liver Dis</edrn:journal>
    <bmdb:Published>2008 Dec</bmdb:Published>
    <edrn:pmid>18799374</edrn:pmid>
  </edrntype:Publication>
  <edrntype:Publication rdf:about="http://edrn.jpl.nasa.gov/bmdb/publications/view/58">
    <dc:title>HPP1: a transmembrane protein-encoding gene commonly methylated in colorectal polyps and cancers.</dc:title>
    <dc:author>Leggett BA</dc:author>
    <edrn:journal>Proc Natl Acad Sci U S A</edrn:journal>
    <bmdb:Published>2001 Jan 2</bmdb:Published>
    <edrn:pmid>11120884</edrn:pmid>
  </edrntype:Publication>
  <edrntype:Publication rdf:about="http://edrn.jpl.nasa.gov/bmdb/publications/view/59">
    <dc:title>Hypermethylation of the AKAP12 promoter is a biomarker of Barrett&amp;apos;s-associated esophageal neoplastic progression.</dc:title>
    <dc:author>Meltzer SJ</dc:author>
    <edrn:journal>Cancer Epidemiol Biomarkers Prev</edrn:journal>
    <bmdb:Published>2008 Jan</bmdb:Published>
    <edrn:pmid>18199717</edrn:pmid>
  </edrntype:Publication>
  <edrntype:Publication rdf:about="http://edrn.jpl.nasa.gov/bmdb/publications/view/60">
    <dc:title>A genome-wide search identifies epigenetic silencing of somatostatin, tachykinin-1, and 5 other genes in colon cancer.</dc:title>
    <dc:author>Meltzer SJ</dc:author>
    <edrn:journal>Gastroenterology</edrn:journal>
    <bmdb:Published>2006 Sep</bmdb:Published>
    <edrn:pmid>16952549</edrn:pmid>
  </edrntype:Publication>
  <edrntype:Publication rdf:about="http://edrn.jpl.nasa.gov/bmdb/publications/view/61">
    <dc:title>AKAP12/Gravin is inactivated by epigenetic mechanism in human gastric carcinoma and shows growth suppressor activity.</dc:title>
    <dc:author>Bang YJ</dc:author>
    <edrn:journal>Oncogene</edrn:journal>
    <bmdb:Published>2004 Sep 16</bmdb:Published>
    <edrn:pmid>15258566</edrn:pmid>
  </edrntype:Publication>
  <edrntype:Publication rdf:about="http://edrn.jpl.nasa.gov/bmdb/publications/view/62">
    <dc:title>Hypermethylation of tachykinin-1 is a potential biomarker in human esophageal cancer.</dc:title>
    <dc:author>Meltzer SJ</dc:author>
    <edrn:journal>Clin Cancer Res</edrn:journal>
    <bmdb:Published>2007 Nov 1</bmdb:Published>
    <edrn:pmid>17975140</edrn:pmid>
  </edrntype:Publication>
  <edrntype:Publication rdf:about="http://edrn.jpl.nasa.gov/bmdb/publications/view/63">
    <dc:title>Aberrant silencing of the endocrine peptide gene tachykinin-1 in gastric cancer.</dc:title>
    <dc:author>Mori Y</dc:author>
    <edrn:journal>Biochem Biophys Res Commun</edrn:journal>
    <bmdb:Published>2009 Jan 16</bmdb:Published>
    <edrn:pmid>19046942</edrn:pmid>
  </edrntype:Publication>
  <edrntype:Publication rdf:about="http://edrn.jpl.nasa.gov/bmdb/publications/view/64">
    <dc:title>Hypermethylation of p16 gene promoter correlates with loss of p16 expression that results in poorer prognosis in esophageal squamous cell carcinomas.</dc:title>
    <dc:author>Kawahara K</dc:author>
    <edrn:journal>Dis Esophagus</edrn:journal>
    <bmdb:Published>2008</bmdb:Published>
    <edrn:pmid>18269647</edrn:pmid>
  </edrntype:Publication>
  <edrntype:Publication rdf:about="http://edrn.jpl.nasa.gov/bmdb/publications/view/65">
    <dc:title>Promoter hypermethylation and quantitative expression analysis of CDKN2A (p14ARF and p16INK4a) gene in esophageal squamous cell carcinoma.</dc:title>
    <dc:author>Maehara Y</dc:author>
    <edrn:journal>Anticancer Res</edrn:journal>
    <bmdb:Published>2007 Sep-Oct</bmdb:Published>
    <edrn:pmid>17970080</edrn:pmid>
  </edrntype:Publication>
  <edrntype:Publication rdf:about="http://edrn.jpl.nasa.gov/bmdb/publications/view/66">
    <dc:title>Antibody array profiling reveals serum TSP-1 as a marker to distinguish benign from malignant prostatic disease.</dc:title>
    <dc:author>Haab BB</dc:author>
    <edrn:journal>Prostate</edrn:journal>
    <bmdb:Published>2007 Feb 15</bmdb:Published>
    <edrn:pmid>17192876</edrn:pmid>
  </edrntype:Publication>
  <edrntype:Publication rdf:about="http://edrn.jpl.nasa.gov/bmdb/publications/view/67">
    <dc:title>Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate.</dc:title>
    <dc:author>Redwine E</dc:author>
    <edrn:journal>N Engl J Med</edrn:journal>
    <bmdb:Published>1987 Oct 8</bmdb:Published>
    <edrn:pmid>2442609</edrn:pmid>
  </edrntype:Publication>
  <edrntype:Publication rdf:about="http://edrn.jpl.nasa.gov/bmdb/publications/view/68">
    <dc:title>Mesothelin-family proteins and diagnosis of mesothelioma.</dc:title>
    <dc:author>Hellstrom I</dc:author>
    <edrn:journal>Lancet</edrn:journal>
    <bmdb:Published>2003 Nov 15</bmdb:Published>
    <edrn:pmid>14630441</edrn:pmid>
  </edrntype:Publication>
  <edrntype:Publication rdf:about="http://edrn.jpl.nasa.gov/bmdb/publications/view/69">
    <dc:title>Serum human glandular kallikrein 2 (hK2) for distinguishing stage and grade of prostate cancer.</dc:title>
    <dc:author>Diamandis EP</dc:author>
    <edrn:journal>Int J Urol</edrn:journal>
    <bmdb:Published>2006 Mar</bmdb:Published>
    <edrn:pmid>16643616</edrn:pmid>
  </edrntype:Publication>
  <edrntype:Publication rdf:about="http://edrn.jpl.nasa.gov/bmdb/publications/view/70">
    <dc:title>hK2 and free PSA, a prognostic combination in predicting minimal prostate cancer in screen-detected men within the PSA range 4-10 ng/ml.</dc:title>
    <dc:author>Schröder FH</dc:author>
    <edrn:journal>Eur Urol</edrn:journal>
    <bmdb:Published>2007 Nov</bmdb:Published>
    <edrn:pmid>17499425</edrn:pmid>
  </edrntype:Publication>
  <edrntype:Publication rdf:about="http://edrn.jpl.nasa.gov/bmdb/publications/view/71">
    <dc:title>Kallikrein 4 is a predominantly nuclear protein and is overexpressed in prostate cancer.</dc:title>
    <dc:author>Saatcioglu F</dc:author>
    <edrn:journal>Cancer Res</edrn:journal>
    <bmdb:Published>2004 Apr 1</bmdb:Published>
    <edrn:pmid>15059887</edrn:pmid>
  </edrntype:Publication>
  <edrntype:Publication rdf:about="http://edrn.jpl.nasa.gov/bmdb/publications/view/72">
    <dc:title>Compartmentalized expression of kallikrein 4 (KLK4/hK4) isoforms in prostate cancer: nuclear, cytoplasmic and secreted forms.</dc:title>
    <dc:author>Clements JA</dc:author>
    <edrn:journal>Endocr Relat Cancer</edrn:journal>
    <bmdb:Published>2005 Dec</bmdb:Published>
    <edrn:pmid>16322328</edrn:pmid>
  </edrntype:Publication>
  <edrntype:Publication rdf:about="http://edrn.jpl.nasa.gov/bmdb/publications/view/73">
    <dc:title>Autoantibody profiling for cancer detection.</dc:title>
    <dc:author>Hanash S</dc:author>
    <edrn:journal>Clin Lab Med</edrn:journal>
    <bmdb:Published>2009 Mar</bmdb:Published>
    <edrn:pmid>19389549</edrn:pmid>
  </edrntype:Publication>
  <edrntype:Publication rdf:about="http://edrn.jpl.nasa.gov/bmdb/publications/view/74">
    <dc:title>Proteomics-based identification of RS/DJ-1 as a novel circulating tumor antigen in breast cancer.</dc:title>
    <dc:author>Hanash SM</dc:author>
    <edrn:journal>Clin Cancer Res</edrn:journal>
    <bmdb:Published>2001 Nov</bmdb:Published>
    <edrn:pmid>11705844</edrn:pmid>
  </edrntype:Publication>
  <edrntype:Publication rdf:about="http://edrn.jpl.nasa.gov/bmdb/publications/view/75">
    <dc:title>Proteomics-based identification of protein gene product 9.5 as a tumor antigen that induces a humoral immune response in lung cancer.</dc:title>
    <dc:author>Hanash S</dc:author>
    <edrn:journal>Cancer Res</edrn:journal>
    <bmdb:Published>2001 Nov 1</bmdb:Published>
    <edrn:pmid>11691811</edrn:pmid>
  </edrntype:Publication>
  <edrntype:Publication rdf:about="http://edrn.jpl.nasa.gov/bmdb/publications/view/76">
    <dc:title>Increased mRNA expression of a laminin-binding protein in human colon carcinoma: complete sequence of a full-length cDNA encoding the protein.</dc:title>
    <dc:author>Chen LB</dc:author>
    <edrn:journal>Proc Natl Acad Sci U S A</edrn:journal>
    <bmdb:Published>1988 Sep</bmdb:Published>
    <edrn:pmid>2970639</edrn:pmid>
  </edrntype:Publication>
  <edrntype:Publication rdf:about="http://edrn.jpl.nasa.gov/bmdb/publications/view/77">
    <dc:title>Evidence for a precursor of the high-affinity metastasis-associated murine laminin receptor.</dc:title>
    <dc:author>Sobel ME</dc:author>
    <edrn:journal>Biochemistry</edrn:journal>
    <bmdb:Published>1989 Sep 5</bmdb:Published>
    <edrn:pmid>2531008</edrn:pmid>
  </edrntype:Publication>
  <edrntype:Publication rdf:about="http://edrn.jpl.nasa.gov/bmdb/publications/view/78">
    <dc:title>Isolation of a laminin-binding protein from muscle cell membranes.</dc:title>
    <dc:author>Mark KV</dc:author>
    <edrn:journal>EMBO J</edrn:journal>
    <bmdb:Published>1983</bmdb:Published>
    <edrn:pmid>16453457</edrn:pmid>
  </edrntype:Publication>
  <edrntype:Publication rdf:about="http://edrn.jpl.nasa.gov/bmdb/publications/view/79">
    <dc:title>A novel isoform of a kallikrein-like protease, TLSP/hippostasin, (PRSS20), is expressed in the human brain and prostate.</dc:title>
    <dc:author>Yamaguchi N</dc:author>
    <edrn:journal>Biochem Biophys Res Commun</edrn:journal>
    <bmdb:Published>2000 May 27</bmdb:Published>
    <edrn:pmid>10872828</edrn:pmid>
  </edrntype:Publication>
  <edrntype:Publication rdf:about="http://edrn.jpl.nasa.gov/bmdb/publications/view/80">
    <dc:title>The use of kallikrein-related peptidases as adjuvant prognostic markers in colorectal cancer.</dc:title>
    <dc:author>Diamandis EP</dc:author>
    <edrn:journal>Br J Cancer</edrn:journal>
    <bmdb:Published>2009 May 19</bmdb:Published>
    <edrn:pmid>19367279</edrn:pmid>
  </edrntype:Publication>
  <edrntype:Publication rdf:about="http://edrn.jpl.nasa.gov/bmdb/publications/view/81">
    <dc:title>A multicenter, double-blinded validation study of methylation biomarkers for progression prediction in Barrett&amp;apos;s esophagus.</dc:title>
    <dc:author>Meltzer SJ</dc:author>
    <edrn:journal>Cancer Res</edrn:journal>
    <bmdb:Published>2009 May 15</bmdb:Published>
    <edrn:pmid>19435894</edrn:pmid>
  </edrntype:Publication>
  <edrntype:Publication rdf:about="http://edrn.jpl.nasa.gov/bmdb/publications/view/82">
    <dc:title>Ovarian carcinoma subtypes are different diseases: implications for biomarker studies.</dc:title>
    <dc:author>Huntsman D</dc:author>
    <edrn:journal>PLoS Med</edrn:journal>
    <bmdb:Published>2008 Dec 2</bmdb:Published>
    <edrn:pmid>19053170</edrn:pmid>
  </edrntype:Publication>
  <edrntype:Publication rdf:about="http://edrn.jpl.nasa.gov/bmdb/publications/view/83">
    <dc:title>Insulin-like growth factor binding protein 2 promotes ovarian cancer cell invasion.</dc:title>
    <dc:author>Zhang W</dc:author>
    <edrn:journal>Mol Cancer</edrn:journal>
    <bmdb:Published>2005 Feb 2</bmdb:Published>
    <edrn:pmid>15686601</edrn:pmid>
  </edrntype:Publication>
  <edrntype:Publication rdf:about="http://edrn.jpl.nasa.gov/bmdb/publications/view/84">
    <dc:title>Expression profiling identifies genes involved in neoplastic transformation of serous ovarian cancer.</dc:title>
    <dc:author>Boyle GM</dc:author>
    <edrn:journal>BMC Cancer</edrn:journal>
    <bmdb:Published>2009 Oct 23</bmdb:Published>
    <edrn:pmid>19849863</edrn:pmid>
  </edrntype:Publication>
</rdf:RDF>
